Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
86.11
+1.45 (1.71%)
At close: Dec 5, 2025, 4:00 PM EST
87.73
+1.63 (1.89%)
After-hours: Dec 5, 2025, 7:59 PM EST

Corcept Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
9,0575,2803,3482,1862,0973,039
Upgrade
Market Cap Growth
64.28%57.69%53.13%4.24%-30.98%119.78%
Upgrade
Enterprise Value
8,5394,7392,9331,7871,6032,598
Upgrade
Last Close Price
86.1150.3932.4820.3119.8026.16
Upgrade
PE Ratio
98.5837.7831.7421.5918.6428.67
Upgrade
Forward PE
111.2532.1132.6119.9521.0132.91
Upgrade
PS Ratio
12.067.826.945.445.738.59
Upgrade
PB Ratio
14.327.776.614.365.585.81
Upgrade
P/TBV Ratio
14.337.776.614.365.585.81
Upgrade
P/FCF Ratio
55.5326.9526.3818.2312.5320.16
Upgrade
P/OCF Ratio
55.4426.6626.3618.1712.4920.00
Upgrade
EV/Sales Ratio
11.527.026.084.454.387.34
Upgrade
EV/EBITDA Ratio
128.0034.4027.0815.6912.7320.18
Upgrade
EV/EBIT Ratio
130.2334.6027.3415.8712.8820.26
Upgrade
EV/FCF Ratio
52.3624.1923.1214.909.5817.24
Upgrade
Debt / Equity Ratio
0.010.0100.000.000.01
Upgrade
Debt / EBITDA Ratio
0.090.050.000.010.000.02
Upgrade
Debt / FCF Ratio
0.040.040.000.010.000.02
Upgrade
Asset Turnover
0.920.920.800.800.740.72
Upgrade
Inventory Turnover
1.311.080.940.971.071.08
Upgrade
Quick Ratio
2.853.114.056.605.319.86
Upgrade
Current Ratio
3.143.354.396.895.6110.07
Upgrade
Return on Equity (ROE)
16.70%23.81%21.05%23.11%25.03%23.70%
Upgrade
Return on Assets (ROA)
5.10%11.71%11.13%13.98%15.63%16.29%
Upgrade
Return on Capital (ROIC)
6.38%14.34%13.28%16.01%17.25%17.79%
Upgrade
Return on Capital Employed (ROCE)
10.10%19.60%20.80%22.00%33.10%24.50%
Upgrade
Earnings Yield
1.16%2.67%3.17%4.64%5.36%3.49%
Upgrade
FCF Yield
1.80%3.71%3.79%5.48%7.98%4.96%
Upgrade
Buyback Yield / Dilution
-7.55%-1.55%3.64%7.94%-1.42%-1.33%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.